序号 |
标题 |
次数 |
作者 |
发布时间 |
78886 |
DOTA-Tyr(3)-奥曲肽, DOTA-Tyr(3)-Octreotide |
68 |
wyh |
2024-12-03 |
78887 |
AgNPs–pytz(3,6-二(吡啶-2-基)-1,2,4,5-四嗪包覆的银纳米粒子) |
86 |
WYQ |
2024-12-03 |
78888 |
3,6-di(pyridin-2-yl)-1,2,4,5-s-tetrazine (pytz,3,6-二(吡啶-2-基)-1,4-二氢-1,2,4,5-四嗪) |
115 |
WYQ |
2024-12-03 |
78889 |
DOTA-叶酸偶联物,DOTA-Folate |
117 |
wyh |
2024-12-03 |
78890 |
CQDs-DOTA-Yb,镱-DOTA螯合物功能化碳量子点 |
95 |
wyh |
2024-12-03 |
78891 |
3,6-dihydrazino-s-tetrazine (DHT,3,6-二肼基-s-四嗪) |
107 |
WYQ |
2024-12-03 |
78892 |
BCN-PEG-PAMAM ,环丙烷环辛炔-聚乙二醇-聚酰胺 |
89 |
zyl |
2024-12-03 |
78893 |
(DNAZTzDMP)2Ni(H2O)2][NO3]2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
95 |
WYQ |
2024-12-03 |
78894 |
AB1-HLys-DOTA,DOTA偶联阳离子肽 |
83 |
wyh |
2024-12-03 |
78895 |
PAMAM-PEG-CKAAKN 树枝状大分子聚酰胺胺-聚乙二醇-CKAAKN多肽 |
92 |
zyl |
2024-12-03 |
78896 |
(NH2TzDMP)3Ni][NO3]2;3-氨基-6-(3,5-二甲基吡唑)四嗪配合物 |
73 |
WYQ |
2024-12-03 |
78897 |
(DNAZTzDMP)2Co(H2O)2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
108 |
WYQ |
2024-12-03 |
78898 |
DOTA-1-nal 3-奥曲肽,Ga-DOTA-1-Nal3-octreotide |
66 |
wyh |
2024-12-03 |
78899 |
PAMAM-PEG-SP94 树枝状大分子聚酰胺胺-聚乙二醇-SP94多肽 |
93 |
zyl |
2024-12-03 |
78900 |
[(DNAZTzDMP)2Co(H2O)2](3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物) |
121 |
WYQ |
2024-12-03 |
78901 |
LLP2A-DOTA-PEG(2000), LLP2A-DOTA-聚乙二醇(2000) |
81 |
wyh |
2024-12-03 |
78902 |
[(NH2TzDMP)2Co(H2O)(NO3)][NO3](3-氨基-6-(3,5-二甲基吡唑)四嗪配合物) |
76 |
WYQ |
2024-12-03 |
78903 |
3-(3,3'-dinitroazetidine)-6-(3,5-dimethylpyrazole)tetrazine(DNAZTzDMP) |
93 |
WYQ |
2024-12-03 |
78904 |
PAMAM-PEG-PTP 树枝状大分子聚酰胺胺-聚乙二醇-PTP多肽 |
88 |
zyl |
2024-12-03 |
78905 |
DOTA-SSTR;DOTA修饰生长抑素受体SSTR |
137 |
wyh |
2024-12-03 |
78906 |
NOTA-PEG(7)-Tz;大环化合物-七聚乙二醇-四嗪;NOTA-PEG(7)-Tetrazine |
101 |
WYQ |
2024-12-03 |
78907 |
PAMAM-PEG-RGDS 树枝状大分子聚酰胺胺-聚乙二醇-RGDS多肽 |
89 |
zyl |
2024-12-03 |
78908 |
PEGylated tetrazine;PEG4-Tz;聚乙二醇化四嗪;PEGylated Tz |
127 |
WYQ |
2024-12-03 |
78909 |
DOTA-ZOL, DOTA-唑来膦酸 |
79 |
wyh |
2024-12-03 |
78910 |
NHS-s-s-tetrazine;N-羟基琥珀酰亚胺-双硫键-四嗪;NHS-s-s-Tz |
106 |
WYQ |
2024-12-03 |
78911 |
PAMAM-PEG-c(RGDfC) ,树枝状大分子聚酰胺胺-聚乙二醇-c(RGDfC)多肽 |
135 |
zyl |
2024-12-03 |
78912 |
3-amino-6-(3,5-dimethylpyrazole)tetrazine(NH2TzDMP、3-氨基-6-(3,5-二甲基吡唑)四嗪) |
72 |
WYQ |
2024-12-03 |
78913 |
DOTA-cyclo(RGDyK) 生物医药探针 |
79 |
zcy |
2024-12-03 |
78914 |
Gd-DOTA-氮氧化合物,Gd-DOTA-NOx |
82 |
wyh |
2024-12-03 |
78915 |
PAMAM-PEG-Angiopep-2,树枝状大分子聚酰胺胺-聚乙二醇-Angiope-2多肽 |
92 |
zyl |
2024-12-03 |
78916 |
cas:250612-06-7 DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 DOTA-RGD探针二聚体 |
74 |
zcy |
2024-12-03 |
78917 |
MF-AspDOTA树脂 ,环烯配体AspDOTA功能化三聚氰胺-甲醛(MF)树脂 |
90 |
wyh |
2024-12-03 |
78918 |
DOTA-Octreotide 大环配体-奥曲肽 |
88 |
zcy |
2024-12-03 |
78919 |
[18F]F-Tz-PEG11-NODA;[18F]F-四嗪-聚(乙二醇)11-1,4,7-三氮杂环壬烷-1,4-二乙酸 |
110 |
WYQ |
2024-12-03 |
78920 |
PAMAMG5-SS-PEG2k 聚酰胺胺-双硫键-聚乙二醇 |
165 |
zyl |
2024-12-03 |
78921 |
5-BOTP-NOTA,5-BOTP偶联NOTA双功能螯合剂 |
137 |
wyh |
2024-12-03 |
78922 |
NOTA-Bn-NCS,147597-66-8 |
69 |
zcy |
2024-12-03 |
78923 |
(64)Cu-Tz-SarAr(64铜-四嗪-SarAr、(64)Cu-Tetrazine-SarAr) |
173 |
WYQ |
2024-12-03 |
78924 |
TA IN-CTLaunp,DOTA偶联乳糖修饰的壳聚糖聚合物(CTLChitlac) |
87 |
wyh |
2024-12-03 |
78925 |
CY5.5-PAMAM(G6)PEG2000-MAL 荧光CY5.5-聚酰胺胺(G6)-聚乙二醇-马来酰亚胺 |
95 |
zyl |
2024-12-03 |
78926 |
CB-TE2A;313229-90-2 |
92 |
zcy |
2024-12-03 |
78927 |
[99mTc]HYNIC-PEG11-Tz;[99mTc]联肼尼克酰胺-十一聚乙二醇-四嗪;[99mTc]HYNIC-PEG11-Tetrazine |
73 |
WYQ |
2024-12-03 |
78928 |
DOTA缀合的GF-17,DOTA-GF-17 |
230 |
wyh |
2024-12-03 |
78929 |
DOTA-Tetrazine(又称DOTA-TZ) |
83 |
WYQ |
2024-12-03 |
78930 |
PNIPAMAM-PEG-phosphoricacid,树枝状聚(N-异丙基丙烯酰胺)-聚乙二醇-磷酸 |
98 |
zyl |
2024-12-03 |